-
摘要:目的
分析湖北省肿瘤登记地区2012年恶性肿瘤的发病与死亡流行特征。
方法收集整理2012年湖北省肿瘤登记地区上报的恶性肿瘤发病与死亡数据，计算发病/死亡粗率、年龄别发病（死亡）率，0~74累积率等指标。
结果2012年湖北省肿瘤登记地区覆盖人口数为8 221 036人（其中男性4 183 884人，女性4 037 152人）。新发病例数24 182例，发病粗率为294.15/10万（男性319.92/10万，女性267.44/10万），中国人口标化率（用2000年中国人口）为194.33/10万，世界人口标化率为210.93/10万。恶性肿瘤死亡病例14 459例，死亡粗率为175.88/10万 ，中标率是111.20/10万，世标率125.76/10万。湖北省肿瘤登记地区的恶性肿瘤发病首位为肺癌，其次为乳腺癌、肝癌、结直肠癌、胃癌、子宫颈癌、食管癌、甲状腺癌、前列腺癌和卵巢癌。占全部恶性肿瘤发病的74.35%。恶性肿瘤死亡前十位分别为肺癌、肝癌、胃癌、结直肠癌、乳腺癌、食管癌、胰腺癌、淋巴瘤、子宫颈癌及前列腺癌。占全部恶性肿瘤死亡的81.05%。
结论湖北省肿瘤登记地区发病主要癌种为肺癌、乳腺癌、消化系统肿瘤。湖北肿瘤登记城市地区甲状腺癌发病率较高需引起重视。
Abstract:ObjectiveTo analyse the cancer incidence and mortality in Hubei cancer registries in 2012.
MethodsThe data from Hubei cancer registries were collected to calculate the crude rate,age-standardize rate and 0-74 accumulative rate.
ResultsHubei cancer registration area covered a population of 8 221 036 (male 4 183 884 cases,female 4 037 152 cases)in 2012. The estimates of new cancer cases and cancer deaths were 24 182 and 14 459. The crude incidence was 294.15/105(male 319.92/105,female 267.44/105) . Age-standardized incidences by Chinese standard population (ASR China 2000) and by World standard population (ASR world 2000) were 194.33/105 and 210.93/105. The crude mortality was 175.88/105,and the age-standardized mortality by ASR China 2000 and ASR world 2000 were 111.20/105 and 125.76/105 respectively. Lung cancer was the leading cause of cancer new cases,followed by breast cancer,liver cancer,colorectal cancer,gastric cancer,cervical cancer,esophageal cancer,thyroid cancer,prostate cancer,ovarian cancer,accounting for 74.35% of all cancer incidences in Hubei registration areas. The top 10 cancer deaths were lung cancer,liver cancer,gastric cancer,colorectal cancer,breast cancer,esophageal cancer,pancreatic cancer,lymphoma,cervical cancer,prostate cancer,accounting for 81.05% of all cancer deaths.
ConclusionThe main cancer types in the cancer registries of Hubei Province are lung cancer,breast cancer,and digestive malignancies. The high incidence of thyroid cancer in the urban area of Hubei cancer registries should be required close attention.
-
Key words:
- Malignant tumor /
- Incidence /
- Mortality /
- Hubei /
- Cancer registry
-
致谢: 在此谨对湖北省各肿瘤登记处相关工作人员在资料收集、整理、查重、补漏、数据库录入过程中付出的辛勤努力表示衷心感谢！
-
![]()
图 1 2012年湖北省肿瘤登记地区恶性肿瘤年龄别发病情况
Figure 1 Age-specific cancer incidence in Hubei cancer registries,2012
![]()
图 2 2012年湖北省肿瘤登记地区恶性肿瘤年龄别死亡情况
Figure 2 Age-specific cancer mortality in Hubei cancer registries,2012
表 1 2012年湖北省肿瘤登记地区MV%、DCO%及M/I
Table 1 Data quality evaluation in Hubei cancer registration areas,2012
下载: 导出CSV
表 3 2012年湖北省肿瘤登记地区恶性肿瘤年龄别发病率 (1/10万)
Table 3 Age-specific cancer incidence in Hubei cancer registries,2012 (1/105)
下载: 导出CSV
表 4 2012年湖北省肿瘤登记地区恶性肿瘤发病前十位
Table 4 Top 10 cancer incidence in Hubei cancer registries,2012
下载: 导出CSV
表 6 2012年湖北省肿瘤登记地区癌症年龄别死亡率 (1/105)
Table 6 Age-specific cancer mortality in Hubei cancer registries,2012 (1/105)
下载: 导出CSV
表 7 2012年湖北省肿瘤登记地区恶性肿瘤死亡前十位
Table 7 Top 10 cancer mortality in Hubei cancer registries,2012
下载: 导出CSV
-
[1] Torre LA,Bray F,Siegel RL,et al. Global cancer statistics,2012[J]. CA Cancer J Clin,2015,65(2): 87-108. doi: 10.3322/caac.21262
[1] Torre LA, Bray F, Siegel RL, et al. Global cancer statistics, 2012[J]. CA Cancer J Clin, 2015, 65(2): 87-108. [2] 全国肿瘤登记中心.中国肿瘤登记工作指导手册[M]. 北京： 中国协和医科大学出版社, 2004: 48-50. [The national central cancer registry. guideline for Chinese cancer registration [M]. Beijing: Peking union medical college press, 2004: 48-50.] [2] 全国肿瘤登记中心.中国肿瘤登记工作指导手册[M]. 北京：中国协和医科大学出版社,2004: 48-50. The national central cancer registry. guideline for Chinese cancer registration [M]. Beijing: Peking union medical college press,2004: 48-50.
[3] Edited by MP, Curado B, Edwards HR, et al. Cancer incidence in Five Continents Vol IX[M]. Lyon: IARC Sci Publ, 2008: 1-837. [3] Edited by MP,Curado B,Edwards HR,et al. Cancer incidence in Five Continents Vol IX[M]. Lyon: IARC Sci Publ,2008: 1-837.
[4] Felay J. The IARCcrg Tools program. http://www.iacr.com.fr/ iarccrgtools.htm. IACR. Lyon. 2006. [4] Felay J. The IARCcrg Tools program. http://www.iacr.com.fr/iarccrgtools.htm. IACR. Lyon. 2006.
[5] 陈万青,郑荣寿,张思维,等. 2012年中国恶性肿瘤发病和死亡分析[J]. 中国肿瘤,2016,25(1): 1-8. Chen WQ,Zheng RS,Zhang SW,et al. Report of cancer incidence and mortality in China,2012[J]. Zhongguo Zhong Liu,2016,25(1): 1-8.
[5] 陈万青, 郑荣寿, 张思维, 等. 2012年中国恶性肿瘤发病和死 亡分析[J]. 中国肿瘤, 2016, 25(1): 1-8. [Chen WQ, Zheng RS, Zhang SW, et al. Report of cancer incidence and mortality in China, 2012[J]. Zhongguo Zhong Liu, 2016, 25(1): 1-8.] [6] 王成增,孙喜斌. 2015河南省肿瘤登记年报[M]. 北京: 军事医学科学出版社,2015: 138. Wang CZ,Sun XB. 2015 Cancer registry annual report in He'nan Province[M]. Beijing: Military Medical Science Press,2015: 138.
[6] 王成增, 孙喜斌. 2015河南省肿瘤登记年报[M]. 北京: 军事 医学科学出版社, 2015: 138. [Wang CZ, Sun XB. 2015 Cancer registry annual report in Henan Province[M]. Beijing: Military Medical Science Press, 2015: 138.] [7] Schneider AB, Ron E, Lubin J, et al. Dose-response relationships for radiation-induced thyroid cancer and thyroid nodules: evidence for the prolonged effects of radiation on the thyroid[J]. J Clin Endocrinol Metab, 1993, 77(2): 362-9. [7] Schneider AB,Ron E,Lubin J,et al. Dose-response relationships for radiation-induced thyroid cancer and thyroid nodules: evidence for the prolonged effects of radiation on the thyroid[J]. J Clin Endocrinol Metab,1993,77(2): 362-9. http://cn.bing.com/academic/profile?id=2033636516&encoded=0&v=paper_preview&mkt=zh-cn
[8] La Vecchia C,Malvezzi M,Bosetti C,et al. Thyroid cancer mortality and incidence: A global overview[J]. Int J Cancer,2015,136(9): 2187-95. doi: 10.1002/ijc.v136.9
[8] La Vecchia C, Malvezzi M, Bosetti C, et al. Thyroid cancer mortality and incidence: A global overview[J]. Int J Cancer, 2015, 136(9): 2187-95. [9] O'Grady TJ, Gates MA, Boscoe FP. Thyroid cancer incidence attributable to overdiagnosis in the United States 1981-2011[J]. Int J Cancer, 2015, 137(11): 2664-73. [9] O'Grady TJ,Gates MA,Boscoe FP. Thyroid cancer incidence attributable to overdiagnosis in the United States 1981-2011[J]. Int J Cancer,2015,137(11): 2664-73. doi: 10.1002/ijc.v137.11
[10] 杨雷, 王宁. 甲状腺癌流行病学研究进展[J]. 中华预防医学杂 志, 2014, 48(8): 744-8. [Yang L,Wang N. Advances in thyroid cancer epidemiology[J]. Zhonghua Yu Fang Yi Xue Za Zhi, 2014, 48(8): 744-8.] [10] 杨雷,王宁. 甲状腺癌流行病学研究进展[J]. 中华预防医学杂志,2014,48(8): 744-8. Yang L,Wang N. Advances in thyroid cancer epidemiology[J]. Zhonghua Yu Fang Yi Xue Za Zhi,2014,48(8): 744-8.
计量
- 文章访问数: 2063
- HTML全文浏览量: 476
- PDF下载量: 525
